Neurosoft Bioelectronics
PrivateLast Round
Seed
May 20, 2026
Total Funding Raised
$18.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Neurosoft Bioelectronics is a neurotechnology company that develops and manufactures soft, elastic, and minimally invasive brain-computer interfaces (BCIs) and neural implants to monitor, treat, and restore neurological functions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosoft Bioelectronics Comparables
Compare Neurosoft Bioelectronics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axoft | 88% | |
| WISE | 86% | |
| INBRAIN Neuroelectronics | 85% |
Neurosoft Bioelectronics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 20, 2026 | ||||
| Seed | May 20, 2024 | ||||
| Grant | Apr 5, 2022 | ||||
| Convertible Debt | Dec 17, 2021 | ||||
| Grant | Jan 28, 2021 | ||||
Grant | Feb 26, 2020 |
Key People
Founding team and executive leadership
Neurosoft Bioelectronics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Connecticut Innovations | Seed |
| PL Capital | Seed |
| IAG Capital Partners | Seed |
| Swiss National Science Foundation | Grant |
| European Research Council | Grant |
| Skybound Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 62% MoM, reaching 2.8K.
- Jul 17, 2026
Grew 21% QoQ, from 19 to 23 employees.
Neurosoft Bioelectronics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurosoft Bioelectronics's valuation, stock price, and market status.
Is Neurosoft Bioelectronics a public or private company?
Neurosoft Bioelectronics is a private company.
What is the current stock price of Neurosoft Bioelectronics?
Neurosoft Bioelectronics is a private company with no public stock price. No recent secondary market data is available.
How much is Neurosoft Bioelectronics worth (valuation)?
Valuation information for Neurosoft Bioelectronics is not publicly available.
Can I buy Neurosoft Bioelectronics stock?
Neurosoft Bioelectronics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurosoft Bioelectronics's last funding round?
Neurosoft Bioelectronics's most recent funding round was Seed on May 20, 2026.
Who are the main investors in Neurosoft Bioelectronics?
Key investors in Neurosoft Bioelectronics include Skybound Venture Capital.
Will Neurosoft Bioelectronics IPO soon?
No public IPO plans have been announced for Neurosoft Bioelectronics.
How can I track Neurosoft Bioelectronics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurosoft Bioelectronics's secondary market activity and sign up for updates.